Moxian, Inc. (OTCQB: MOXC) is increasing its visibility and influence in Beijing’s marketing space. With its newly-created corporate subsidiary, Moxian Beijing, and a defined expansion strategy, the corporation is focused on growing its sales in Beijing and driving local merchants and users to its social marketing and promotion platform.

Moxian revealed the establishment of Moxian Technologies (Beijing) Co. (Moxian Beijing) in January 2016. As the capital of the People’s Republic of China (PRC) and home to 20 million residents, Beijing is not only the nation’s political and cultural center, it also easily outpaces any other PRC city in terms of economic and commercial opportunity. Setting up Moxian’s subsidiary company in the Dongcheng district of Beijing and in the vicinity of the Guomao business district was thus exceedingly apt. Beijing is a remarkably developed economy city with numerous opportunities for small and medium businesses such as Moxian, Inc.

Moxian Beijing is currently in a 2,000-square-foot space that can house up to 80 employees. To date, the office space is home to 15 employees. To accommodate and ease the progress of corporate growth, the company plans to increase the number of staff in this location over time. In 2016 alone, the company expects to increase its in-house Beijing sales team to 50 salesmen in order to maximize its market penetration.

The foundation of a Beijing office signals a qualitative leap for the company. Since Moxian Beijing’s establishment, it has already entered into a significant cooperation agreement and business relationship with Xinhua New Media Culture Communication Co. For the next five years, Moxian Beijing will serve as the sole reseller of Xinhua ad space in the gaming industry. It will also serve as Xinhua’s exclusive partner in the operation of the Xinhua New Media App gaming platform.

Xinhua New Media App has over 10 million active daily users and over 110 million users in total. As Xinhua’s exclusive gaming partner, Moxian has the opportunity to market its games on the platform while registering and capturing even more active users for the Xinhua New Media App. Users of the app will be rewarded with Moxian Coins (Mo-Coins) and Moxian Points (Mo-Points) when clicking on and interacting with any advertisements. Then, those users can log into the Moxian Platform to redeem their rewards. By collaborating on the Xinhua game platform, Moxian will gradually attract more users to its platform.

The Moxian-Xinhua agreement lays the groundwork for Moxian’s future promotions and developments while steadily and effectively driving the Moxian platform into the mainstream of the Internet. As Moxian establishes a deeper cooperation with Xinhua, it also opens the door for new sources of income for its operations.

For more information, visit the company’s website at www.Moxian.com

Let us hear your thoughts: Moxian, Inc. Message Board

International Stem Cell Corporation (OTCQB: ISCO) builds shareholder value through its research with stem cells, otherwise known as cells that can both proliferate (divide) and change (differentiate) into more specialized cells, such as skin, nerve or liver cells. The most powerful stem cells are known as ‘pluripotent’, as they have the promise of becoming virtually any cell in the human body. The first pluripotent stem cells to be studied were embryonic stem cells (ESC) taken from donated human embryos. ISCO’s new class of pluripotent human stem cells are derived from unfertilized eggs. These stem cells, known as human parthenogenetic stem cells (hPSC) avoid the ethical issues associated with ESC while retaining many of the advantages.

The company’s work does not begin and end with research. International Stem Cell Corporation’s primary goal is to transform its research into treatment for those suffering with moderate to severe Parkinson’s disease, and if recent developments are any indication of the company’s progress in this area, the recent announcement that enrollment has started for its upcoming phase I clinical trial should remove all doubt. The trial is scheduled to take place at the Royal Melbourne Hospital in Australia.

In a news release, Dr. Russell Kern, executive vice president and chief scientific officer of ISCO, recently noted, “Enrollment in this trial is an important milestone… Promising preclinical results support our expectation that ISC-hpNSC will bring a long-needed solution for patients suffering from Parkinson’s disease.”

ISCO is a publicly traded biotechnology company which developed a powerful new stem cell technology called parthenogenesis that could significantly advance the field of regenerative medicine by addressing the problem of immune-rejection. Parthenogenesis (from the Greek parthenos, meaning “virgin” and genesis, meaning “birth”) uses unfertilized human eggs to create hpSC that can be immune-matched to millions of people. A relatively small number of hpSC lines could provide sufficient immune-matched cells to cover a large percentage of the world’s population.

The company’s human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized media to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. International Stem Cell Corporation was founded in 2001 and is headquartered in Carlsbad, California.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

On Monday, Fuling Global Corp. (NASDAQ: FORK), a specialized producer and distributor of environmentally friendly plastic serviceware, announced that CFO Gilbert Lee’s presentation from the VirtualInvestorConferences.com online investor conference series, originally presented on March 3, 2016, is now available for on-demand viewing. The company’s presentation will be available at the convenience of investors – 24 hours a day, seven days a week – for 90 days. Investors and advisors may also download shareholder materials from the “virtual trade booth” for the next three weeks.

To view the full presentation, visit http://dtn.fm/re9Ez

In addition to investment and financial highlights, the presentation includes product information, an industry overview, details on Fuling’s manufacturing and production facilities, and an update on the company’s current research and development activities.

Fuling’s plastic serviceware products include disposable cutlery, drinking straws, cups, plates and other plastic products that are currently used by hundreds of customers, primarily from the U.S. and Europe. Some of the company’s most recognizable customers include Subway, Wendy’s (NASDAQ: WEN), Burger King (NYSE: QSR), KFC (NYSE: YUM) (China only), Walmart (NYSE: WMT), McKesson (NYSE: MCK), and Woolworths (OTC: WLWHY).

VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, is the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform. Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire’s leading-edge online conferencing and investor communications capabilities with BetterInvesting’s extensive retail investor audience network.

For more information, visit http://ir.fulingglobal.com

Oakridge Global Energy Solutions, Inc. (OTCQB: OGES) is making its way to the forefront of the development and manufacture of energy storage products. The company focuses on state-of-the-art technology that is both green and ‘Made in the USA’. Oakridge delivers high-quality cells, batteries, and energy storage systems that are easily stackable, featuring prismatic shapes. Compared to usual cylindrical batteries, these hold 25-30% more energy, which allows for low-cost production and high-margin profits. The many advantages of lithium-ion batteries contribute to the company’s success within the automobile, hobby, and living space markets.

Packed with energy, lithium-ion batteries can be installed within high-power consumption machines like cars, trucks, boats, and motorcycles. Plus, these batteries have a very low rate of discharge, which means if they are left alone for a long period of time, they’ll still start-up like new. To show this, Oakridge completed a 32-day test pitting a lead-acid battery against their Liberty Series lithium-ion battery. One of each was placed in two 2015 Harley Davidson Street Glide Motorcycles and left alone for 32 days. After that, the lead-acid battery had to be replaced, while the other started up perfectly, since very little energy was lost.

Lithium-ion batteries also do not require any maintenance once they’re fitted within a machine. Oakridge’s batteries last 2,000 cycles or five years without needing to be recharged. Fully recharging lithium-ion batteries takes only 30 minutes. Furthermore, if not charged all the way, the batteries will still work without incurring any damage.

Oakridge offers a few models to suit the needs of any energy storage aficionado. The Liberty Series comes custom designed to easily fit motorcycles, snowmobiles, cars, trucks, boats, jet skis, and more. For smaller electronics, such as unmanned aerial and remote controlled vehicles, power tools, and phones, the Patriot Series is the right choice. The company also offers the Freedom Series, which provides clean and silent living space power storage units for RVs and boats, along with hospitals and other commercial buildings which need steady power. All of these batteries guarantee eco-friendliness, high-energy density, cost-effectiveness, and reliability.

Since 1986, Oakridge has focused on customer needs, innovative technology, and harnessing the expertise of team members to propel itself forward. The company looks forward to becoming a major player in the global energy storage community.

For more information, visit www.oakridgeglobalenergy.com

Let us hear your thoughts: Oakridge Global Energy Solutions, Inc. Message Board

Before the opening bell, International Stem Cell Corporation (OTCQB: ISCO) announced entry into a definitive agreement with two institutional healthcare investors and its management team through which the company will raise $6.3 million to fund its upcoming phase I study of human parthenogenetic neural stem cells (ISC-hpNSC). The agreement includes the initial purchase of $6.3 million of ISCO’s convertible preferred stock, in addition to common stock purchase warrants for an additional $25.7 million of the company’s common stock in the future. Through these efforts, the company is set to secure gross proceeds of $2.5 million in cash from the initial purchase, as well as conversion of $3.8 million of outstanding debt. The closing of this offering is expected to occur on or about March 15, 2016, subject to satisfaction of customary closing conditions, as described in the purchase agreement.

“The recurring investment of these healthcare focused institutional investors is in support of and attests to the potential of our technology,” Dr. Andrey Semechkin, co-chairman and chief executive officer of ISCO, stated in this morning’s news release. “The capital raised will help to drive our Phase 1 study of ISC-hpNSC® for the treatment of moderate to severe Parkinson’s disease.”

The announcement of this investment builds on what’s been a strong week for ISCO. On Monday, the company announced the commencement of enrollment for a phase I trial of its innovative ISC-hpNSC for the treatment of moderate to severe Parkinson’s disease after being granted approval by the Melbourne Health Human Research Ethics Committee. ISCO plans to initiate the study at Australia’s Royal Melbourne Hospital in the coming weeks, with management looking forward to preliminary clinical data as early as the fourth quarter of this year.

“With enrollment of patients already underway, we look forward to the end of this year for preliminary safety and efficacy clinical data,” Semechkin concluded.

ISCO’s powerful new stem cell technology, parthenogenesis, promises to significantly advance the field of regenerative medicine by addressing the problem of immune rejection. By utilizing unfertilized human eggs to derive parthenogenetic stem cells that can be immune-matched to millions of people, the company aims to enable treatment of a large percentage of the global population with a relatively small number of ISC-hpNSC lines. Through its phase I study of ISC-hpNSC for the treatment of Parkinson’s disease, the company is targeting a dramatically underserved neurodegenerative indication that directly affects more than seven million people around the world.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

Cancer is the most serious disease in the history of mankind. All families in the U.S. and the world are affected by cancer either directly or indirectly. Men, women, and children of all races, creeds, and religions risk the possibility of being diagnosed with cancer – it does not discriminate. Some startling estimates for 2016 from the American Cancer Society are as follows: 841,390 new cancer cases in males in the U.S.; 843,820 new cancer cases in females in the U.S.; 314,290 deaths from cancer in males in the U.S.; and 281,400 deaths from cancer in females in the U.S.

Immune Therapeutics, Inc. (OTCQB: IMUN) is a biotechnology company applying its patented immunotherapy to combat chronic, life-threatening diseases that affect people around the world. Building on the power of the body’s natural immune system, the company’s pipeline of products and immunotherapy technologies are designed to enhance the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and a variety of autoimmune diseases.

Each year, cancer costs the world more money than any other disease, according to the American Institute of Cancer Research (AICR). Cancer costs $895 billion annually. Comparatively, heart disease costs $753 billion. Nothing else comes close, with traffic accidents and diabetes each costing about $204 billion. The biggest financial impact is in terms of loss of life and productivity, in which cancer accounts for 1.5 percent of global gross domestic product (GDP) losses.

Immunotherapy, also called biologic therapy, is a type of cancer treatment designed to boost the body’s natural defenses to fight the cancer. It uses materials either made by the body or in a laboratory to improve, target, or restore immune system function.

Stimulating the body’s immune system remains one of the most promising approaches to addressing the unmet needs of cancers, HIV, inflammatory disease, autoimmune disease and other chronic infectious diseases. Immune Therapeutics’ immune therapy technology platform has shown the potential to establish a new paradigm to prevent and treat these life-altering diseases, with validating efficacy data from all phase I and phase II clinical trials for such diseases as HIV/AIDS, pancreatic cancer, Crohn’s Disease, liver disease, fibromyalgia and herpes.

Learn more by visiting www.immunetherapeutics.com

Let us hear your thoughts: Immune Therapeutics, Inc. Message Board

For years, franchising has been a long-term growth goal for Giggles N’ Hugs, Inc. (OTCQB: GIGL). Now that the award-winning restaurant chain is finally looking to launch a vast franchising program, it seems like that goal will soon come to pass.

Many highly successful enterprises (e.g. California Pizza Kitchen and Wolfgang Puck Food) have benefited from franchising and expanding beyond company-owned locations. In light of Giggles N’ Hugs’ proven fast-casual concept, which offers a kid-friendly, adult-friendly and family-friendly experience at its various locations in California, the company seems well-placed for long-term success in this area, once it launches.

Franchising presents a major growth opportunity for Giggles N’ Hugs. The global market potential could very well exceed millions of dollars, and, with margins above 25% expected from franchise operations, the strategy also complements core company-owned growth initiatives, which include expanding to additional locations throughout the U.S. in the near term.

Franchising has always been a part of the company’s long-standing growth strategy. Before exploring the promises of franchising however, Giggles N’ Hugs’ chose to refine and perfect the experience at its company-owned locations in order to establish a solid foundation for the entire company. This strong base will ultimately endow the company with the confidence and ability to successfully duplicate the full Giggles N’ Hugs experience through its franchise partners.

Since its establishment in 2008, Giggles N’ Hugs has been focused on honing the experience presented at its restaurants, from start to finish. Presently, each of its locations offers a trendy, family-friendly atmosphere; dedicated play areas that children ten and younger tend to adore; and high-quality menus filled with fresh, local food. Giggles N’ Hugs also features widely popular party packages for families that want to host special celebrations for their kids, along with nightly entertainment, such as concerts, face painting and magic shows. What Giggles N’ Hugs has created are spaces in which parents can come in to relax, kids can play to their hearts’ content and both can enjoy healthy and tasty food offerings.

The various entities who have been actively seeking franchise opportunities with Giggles N’ Hugs since 2008 (when it opened the doors of its first restaurant) seem to agree that it is a thriving, emerging company with excellent growth prospects. Small individual franchisees and large multi-unit franchising operators from Europe, Asia, Latin America, Canada, Australia, the Middle East and almost every major city in the U.S. have repeatedly sought to replicate the company’s concept and success in new markets. For now, Giggles N’ Hugs is exploring and considering the numerous inquiries it has received.

Learn more by visiting www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

Content Checked Holdings, Inc. (OTCQB: CNCK) is arming today’s consumers with data and information to help them fight back against the often emotional allure of food intake. This in turn puts the consumer in the driver’s seat on the dietary road toward achieving vital health targets. The company is playing a leadership role through development of mobile software apps aimed at assisting consumers with dietary preferences and restrictions by helping them make informed food purchasing decisions.

Positioned as shopping tools within the food allergy and intolerances market – which was valued at $13B last year – ContentChecked, SugarChecked and MigraineChecked deliver complementary solutions to consumers dealing with food allergies and sensitivities. The apps go beyond the label, allowing consumers to better understand contents and ingredient make-ups, which are viewed by many as ambiguous. While the consumer shops, they receive recommended alternatives for the types of foods that do not align with their preset dietary settings.

In anticipation of accelerated growth, the company recently announced a strategic partnership with leading New York City-based capital markets advisory firm PCG Advisory Group (PCG). The firm will serve as an advisor for the company’s ongoing investor relations, social media and public relations strategies.

In a recent news release, Kris Finstad, CEO of Content Checked, noted, “Our search for a partner with the capital markets expertise to communicate our story to both institutional and retail investors, while increasing our new media profile and social media engagement, resulted in the most obvious conclusion.” Adding further, “Our engagement of PCG is reflective of their unique capability to provide valuable insight and exposure to our exciting products, partnerships and developing pipeline.”

The partnership appears to be timed nicely with an anticipated revenue strategy for its innovative suite of mobile apps. At the beginning of 2015, the company outlined plans to shift toward a subscription-based revenue model for its apps in an attempt to capitalize on emerging mobile trends. Content Checked’s highly anticipated relaunch and rebranding of its products is expected to take place later this spring.

CNCK develops smartphone applications designed for those dealing with food allergies and intolerances, as well as migraine and chronic headaches, in the United States. The Content Checked apps and supporting database enable users to scan the bar codes affixed to store products to determine if they coincide with their health and dietary restrictions or preferences, helping users personalize shopping lists accordingly. Founded in 2013, the company is headquartered in West Hollywood, California.

For more information, visit www.contentchecked.com

Let us hear your thoughts: ContentChecked Holdings Inc. Message Board

Earlier this week, IEG Holdings Corporation (OTCQX: IEGH) made headlines when it uplisted from the OTCQB® Venture Market to the OTCQX® Best Market, the top tier of the three marketplaces operated by OTC Markets Group. Before becoming eligible to be traded on this tier, companies must undergo a qualitative review by OTC Markets Group and meet a number of strict financial and corporate governance benchmarks. Following its uplisting, IEG Holdings is expected to enjoy increased visibility with investors while distinguishing itself among the most established, investor-focused U.S. and international companies currently traded on the OTC markets.

“IEGH is pleased to have met the stringent financial and corporate governance criteria to be upgraded to the OTCQX market, which is another key step in the growth of the company,” Paul Mathieson, chairman and chief executive officer of IEG Holdings, stated in a Monday news release.

News of IEGH’s uplisting continued to build on what has been a promising start to 2016 for the company. In early January, IEGH announced expansion of its online lending services – marketed under the Mr. Amazing Loans brand – into Kentucky, marking the 17th U.S. state in which it currently offers consumer loans. IEG Holdings’ management team previously set a goal of offering loans in 25 U.S. states by the third quarter of 2016. If this goal is achieved, it would give the company access to approximately 240 million people across the country, which is roughly 75 percent of the U.S. population.

Following its expansion into Kentucky, IEGH achieved record loan volumes for the first month of the year, recording an 85 percent year-over-year increase to $315,000 in January 2016. This growth came as no surprise to investors tracking the company’s recent trajectory. From 2013 to 2015, IEGH achieved a 2,815 percent increase in full-year revenue, growing from $62,949 to more than $1.8 million over the course of just two years. In a recent release, the company attributed this strong performance to the versatility of its online lending website (www.mramazingloans.com), its low acquisition cost lead sources and continued state license expansion.

By uplisting to the OTCQX market, IEG Holdings is now in a formidable strategic position to leverage its recent momentum in an effort to maximize shareholder value. Look for the company to continue its aggressive pursuit of the nationwide expansion of its Mr. Amazing Loans platform in the months to come, establishing a solid foundation upon which to expand its sizable foothold in the multibillion dollar online consumer lending market of the United States.

For more information, visit www.investmentevolution.com

Digital, mobile and card payment platforms continue their steady growth behind vastly improved technologies and advancing secure solutions, with experts believing the trend will take hold of the mainstream market in 2016. News, purchase orders, product updates and current events of note in the markets today involve NXT-ID, Inc. (NASDAQ: NXTD), Heartland Payment Systems Inc. (NYSE: HPY), Visa Inc. (NYSE: V), PayPal Holdings, Inc. (NASDAQ: PYPL), Apple Inc. (NASDAQ: AAPL) and MasterCard Incorporated (NYSE: MA). Another competitor in this space, Alternet Systems, Inc. (OTC: ALYI), invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.

The global mobile payment transaction market will be worth an estimated $2.8 trillion by 2020, up from $392 billion in 2014, representing a compound annual growth rate (CAGR) of 39.2 percent, according to Future Market Insights (http://dtn.fm/5cQJ7). The growth of this segment is astonishing to say the least and should provide excellent opportunities for companies like Alternet Systems.

Being in the right place at the right time, or, in this case, the right business at the right time, is paramount to maximizing a shareholder’s return on investment. With the global population moving rapidly toward mobile payment solutions, the possibilities of this industry are effectively endless.

Alternet Systems best describes its approach to this dynamic space via its mission statement: “To provide innovative solutions that facilitate and expedite commerce, enriching our partners and their customers’ experience, and improving efficiency.” Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new approach to many of the basic functions of daily life.

For more information, visit www.alternetsystems.com

Let us hear your thoughts: Alternet Systems, Inc. Message Board